Stock Events

Stock Events

Arvinas 

$9.36
55
+$0.04+0.48% 18:47 Today

Statistics

Day High
9.36
Day Low
9.36
52W High
14.51
52W Low
6.97
Volume
100
Avg. Volume
-
Mkt Cap
611.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.1
0.13
1.35
2.58
Expected EPS
-0.867149
Actual EPS
N/A

Financials

-30.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
262.6MRevenue
-80.8MNet Income

Analyst Ratings

16.29Average Price Target
The highest estimate is 21.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ARVN. It's not an investment recommendation.
Microsoft
11
MSFT
Apple
9
AAPL
NVIDIA
9
NVDA
Bitcoin
9
BTC.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology company that competes with Arvinas in the development of novel therapeutics for cancer and other serious diseases.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas overlapping with Arvinas, particularly in oncology.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes with Arvinas in the oncology sector, focusing on developing cancer treatments including protein degradation therapies.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Arvinas in researching and developing innovative medicines, including treatments for cancer.
Merck
MRK
Mkt Cap366B
Merck is known for its research-driven pharmaceutical products, competing with Arvinas in the oncology space, particularly in developing cancer therapies.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a research-based biopharmaceutical company that competes with Arvinas in the development of drugs for various diseases, including cancer.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is involved in the discovery of new medicines, competing with Arvinas in the therapeutic area of oncology, among others.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Arvinas through its strong focus on oncology, developing innovative cancer treatments.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company competes with Arvinas in the pharmaceutical sector, focusing on oncology and other areas of unmet medical need.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is a biotechnology company that competes with Arvinas in developing innovative treatments for cancer, among other diseases.

About

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Show more...
CEO
Randy Teel
Employees
246
Country
United States
ISIN
US04335A1051

Listings

BOATS
BOATS
ARVN.BOATS
XNAS
US
ARVN

0 Comments

Share your thoughts

FAQ

What is Arvinas stock price today?▼
The current price of ARVN is $9.36 USD — it has increased by +0.48% in the past 24 hours. Watch Arvinas stock price performance more closely on the chart.
What is Arvinas stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Arvinas stocks are traded under the ticker ARVN.
Is Arvinas stock price growing?▼
ARVN stock has risen by +1.8% compared to the previous week, the month change is a +3.83% rise, over the last year Arvinas has showed a +22.8% increase.
What is Arvinas market cap?▼
Today Arvinas has the market capitalization of 611.69M
When is the next Arvinas earnings date?▼
Arvinas is going to release the next earnings report on November 10, 2026.
What were Arvinas earnings last quarter?▼
ARVN earnings for the last quarter are 2.58 USD per share, whereas the estimation was -0.37 USD resulting in a +789.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Arvinas revenue for the last year?▼
Arvinas revenue for the last year amounts to 262.6M USD.
What is Arvinas net income for the last year?▼
ARVN net income for the last year is -80.8M USD.
How many employees does Arvinas have?▼
As of September 04, 2026, the company has 246 employees.
In which sector is Arvinas located?▼
Arvinas operates in the Health & Wellness sector.
When did Arvinas complete a stock split?▼
Arvinas has not had any recent stock splits.
Where is Arvinas headquartered?▼
Arvinas is headquartered in NEW HAVEN, United States.